Global Hemophilia Treatment Market Report Size, Trends & Growth Opportunity, By Diagnosis, By Product, By Treatment, By Distribution Channel, By Region and forecast till 2027
Report ID : QR1001500 | Industries : Healthcare | Published On :June 2022 | Page Count : 240Global Hemophilia Treatment Market
The global Hemophilia Treatment market size was valued at $11.1 Bn in 2021, and is estimated to reach $15.22 Bn by 2027 with a CAGR of 4.8% from 2021 to 2027.
The study comprises Hemophilia Treatment Market analysis, in which market size, growth rate, and overall attractiveness are evaluated crosswise Component, Application, and end-user categories. The study includes both historical data and an income forecast. During the forecast period, the report discusses Hemophilia Treatment Market drivers and restraints, as well as their impact on demand.
The study consists of a competitive landscape & an analysis of Porter's Five Forces model for the industry. The study offers an up-to-date assessment of the current market situation, as well as the recent trends and drivers, as well as the general market environment. The study covers market estimates & assessments on a global and regional scale.
The study presents a thorough picture of Hemophilia Treatment Market by segmenting it by component, application, end-user, and region. In light of present and future market trends, all of the segments have been studied. The research begins by describing the overall scope of the global market, as well as the feasibility of investments in various market segments, as well as a descriptive section which describes the feasibility of new projects that may succeed in the global market in the near future.
Know more about this report: request for sample pages
Competitive Outlook:
Mergers and Acquisitions, new technology launches, business expansion, partnerships, collaborations & joint ventures, research & development, and geographic growth of leading market participants are all covered in this report on a worldwide and regional basis. The study looks at company market share in order to have a better view of the top players in the Hemophilia Treatment Market industry. The study combines data on each of the market's leading players, including current company profiles, gross margins, sales revenue, sales volume, and product specifications.
Key Players:
The key players profiled in the Hemophilia Treatment market report include Bayer Healthcare, Biogen, Biotest AG, CSL Behring, Ferring B.V., Genentech, Kedrion, Novo Nordisk, and Octapharma among others.
Market Taxonomy
By Treatment
- Plasma-derived coagulation factor concentrate
- Recombinant Coagulation Factor Concentrates
- Desmopressin
- Antifibrinolytic agents
- Gene therapy
By Diagnosis
- Replacement therapy
- Gene Therapy
By Distribution Channel
- Hospital pharmacy
- Retail pharmacy
- Others
By Product
- Plasma-derived coagulation factor concentrates
- Recombinant coagulation factor concentrates
- Desmopressin
- Antifibrinolytic agents
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Global Hemophilia Treatment Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Hemophilia Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Hemophilia Treatment Market, By Diagnosis
5.1 Y-o-Y Growth Comparison, By Diagnosis
5.2 Hemophilia Treatment Market Share Analysis, By Diagnosis
5.3 Hemophilia Treatment Market Size and Forecast, By Diagnosis
5.3.1 Replacement therapy
5.3.2 Gene Therapy
6 Hemophilia Treatment Market, By Product
6.1 Y-o-Y Growth Comparison, By Product
6.2 Hemophilia Treatment Market Share Analysis, By Product
6.3 Hemophilia Treatment Market Size and Forecast, By Product
6.3.1 Plasma-derived coagulation factor concentrates
6.3.2 Recombinant coagulation factor concentrates
6.3.3 Desmopressin
6.3.4 Antifibrinolytic agents
7 Hemophilia Treatment Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Hemophilia Treatment Market Share Analysis, By Distribution Channel
7.3 Hemophilia Treatment Market Size and Forecast, By Distribution Channel
7.3.1 Hospital pharmacy
7.3.2 Retail pharmacy
7.3.3 Others
8 Hemophilia Treatment Market, By Treatment
8.1 Y-o-Y Growth Comparison, By Treatment
8.2 Hemophilia Treatment Market Share Analysis, By Treatment
8.3 Hemophilia Treatment Market Size and Forecast, By Treatment
8.3.1 Plasma-derived coagulation factor concentrate
8.3.2 Recombinant Coagulation Factor Concentrates
8.3.3 Desmopressin
8.3.4 Antifibrinolytic agents
8.3.5 Gene therapy
9 Hemophilia Treatment Market, By Region
9.1 Hemophilia Treatment Market Share Analysis, By Region
9.2 Hemophilia Treatment Market Share Analysis, By Region
9.3 Hemophilia Treatment Market Size and Forecast, By Region
10 North America Hemophilia Treatment Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 North America Hemophilia Treatment Market Share Analysis, By Diagnosis
10.3 North America Hemophilia Treatment Market Size and Forecast, By Product
10.4 North America Hemophilia Treatment Market Size and Forecast, By Distribution Channel
10.4 North America Hemophilia Treatment Market Size and Forecast, By Treatment
10.5 North America Hemophilia Treatment Market Size and Forecast, By Country
10.5.1 U.S.
10.5.2 Canada
10.5.3 Mexico
11 Europe Hemophilia Treatment Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Europe Hemophilia Treatment Market Share Analysis, By Diagnosis
11.3 Europe Hemophilia Treatment Market Size and Forecast, By Product
11.4 Europe Hemophilia Treatment Market Size and Forecast, By Distribution Channel
11.4 Europe Hemophilia Treatment Market Size and Forecast, By Treatment
11.5 Europe Hemophilia Treatment Market Size and Forecast, By Country
11.5.1 Germany
11.5.2 France
11.5.3 UK
11.54. Rest of Europe
12 Asia Pacific Hemophilia Treatment Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Asia Pacific Hemophilia Treatment Market Share Analysis, By Diagnosis
12.3 Asia Pacific Hemophilia Treatment Market Size and Forecast, By Product
12.4 Asia Pacific Hemophilia Treatment Market Size and Forecast, By Distribution Channel
12.4 Asia Pacific Hemophilia Treatment Market Size and Forecast, By Treatment
12.5 Asia Pacific Hemophilia Treatment Market Size and Forecast, By Country
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4. Rest of Asia Pacific
13 Latin America Hemophilia Treatment Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Latin America Hemophilia Treatment Market Share Analysis, By Diagnosis
13.3 Latin America Hemophilia Treatment Market Size and Forecast, By Product
13.4 Latin America Hemophilia Treatment Market Size and Forecast, By Distribution Channel
13.4 Latin America Hemophilia Treatment Market Size and Forecast, By Treatment
13.5 Latin America Hemophilia Treatment Market Size and Forecast, Country
13.5.1. Brazil
13.5.2. Rest of Latin America
14 Middle East Hemophilia Treatment Market Analysis and Forecast (2021-2027)
14.1 Introduction
14.2 Middle East Hemophilia Treatment Market Share Analysis, By Diagnosis
14.3 Middle East Hemophilia Treatment Market Size and Forecast, By Product
14.4 Middle East Hemophilia Treatment Market Size and Forecast, By Distribution Channel
14.4 Middle East Hemophilia Treatment Market Size and Forecast, By Treatment
14.5 Middle East Hemophilia Treatment Market Size and Forecast, By Country
14.5.1. Saudi Arabia
14.5.2. UAE
14.5.3. Egypt
14.5.4. Kuwait
14.5.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Bayer Healthcare
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Biogen
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Biotest AG
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 CSL Behring
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Ferring B.V.
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Genentech
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Kedrion
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Novo Nordisk
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Octapharma
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies